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Abstract
Background: In 1994, an outbreak of Enterobacter sakazakii infections in France occurred in a
neonatal intensive care unit during which 17 neonates were infected. More than half of the infected
neonates had severe clinical symptoms; 7 cases of necrotising enterocolitis (one with abdominal
perforation), one case of septicemia, and one case of meningitis. The other 8 neonates were shown
to be colonized but remained asymptomatic. There were three deaths. Four distinguishable
pulsotypes of E. sakazakii were isolated during the outbreak, and the deaths were attributable to
one pulsotype. This paper compares strains, from the four pulsotypes, for attachment and invasion
of mammalian intestinal cells, macrophage survival and blood-brain barrier invasion. A fourth death
from septic shock also occurred during the E. sakazakii outbreak. This was due to E. cloacae which
at the time of the outbreak had been misidentified as E. sakazakii. This isolate has been included in
this study.
Results: All E. sakazakii strains attached and invaded Caco-2 human epithelial cells, and invaded rat
brain capillary endothelial cells. The majority of strains persisted in macrophage cells for 48 h. Two
strains from fatal NEC and meningitis cases showed the highest invasion rate of Caco-2 intestinal
cells. Their invasion of brain capillary endothelial cells was equivalent or greater than that of the
neonatal  E. coli meningitis strain K1. These strains also had extended spectrum ?-lactamase
activities. E. cloacae differed from E. sakazakii due to the greater attachment and less invasion of
epithelial cells, no survival in macrophages, and less invasion of capillary endothelial brain cells.
Conclusion: While variables such as host factors and treatment strategies determine the outcome
of infection, our in vitro studies evaluated the virulence of the isolates associated with this outbreak.
It was not possible to directly correlate clinical symptoms and outcomes with in vitro studies.
Nevertheless, we have shown the variation in invasive potential of E. sakazakii with intestinal and
blood-brain barrier cells between and within pulsotypes from a neonatal intensive care unit
outbreak.  E. sakazakii strains were able to persist and even replicate for a period within
macrophage cells. These traits appear to facilitate host immune evasion and dissemination.
Background
Enterobacter sakazakii is an opportunistic pathogen associ-
ated with the ingestion of reconstituted infant formula,
and is a rare cause of neonatal meningitis, necrotising
enterocolitis (NEC) and sepsis [1-3]. These cases often
occur among low-birth weight preterm neonates, who are
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generally more susceptible to Gram-negative bacterial
sepsis and endotoxemia which is associated with NEC
[4,5]. The bacterium can persist under desiccated condi-
tions in infant formula for over two years [6]. There have
been a number of reported E. sakazakii outbreaks which
have been attributed to reconstituted infant formula
which may be contaminated at source or during prepara-
tion [7-11]. The virulence of E. sakazakii has been studied
by Pagotto et al. [12] and Mange et al. [13] who showed
the presence of enterotoxins and adhesion to brain cells,
respectively. The influence of endotoxin on increased
translocation of intestinal bacteria and E. sakazakii in the
neonatal rat was demonstrated by Townsend et al. [14].
Recently, Townsend et al. [15] comparatively investigated
several  E. sakazakii strains showing chronic-patterned
brain inflammation in neonatal rats following intracra-
nial inoculation. These studies further demonstrated the
ability of E. sakazakii to invade brain capillary endothelial
cells and persist in human macrophages. The IL-10/IL-12
ratio secreted by these macrophages was high and suggests
a type 2 immune response may be activated early during
E. sakazakii infection that is inadequate to clear the infec-
tion [15]. Previously, we reported a NICU outbreak in
which 17 neonates were infected, and 3 neonates died [6].
Three distinguishable E. sakazakii pulsotypes were isolated
from neonates and reconstituted formula. A fourth pulso-
type was isolated from an unopened tin of powdered
infant formula. Pulsotype 2 was associated with the three
deaths, and therefore was potentially more virulent. A
pulsotype is determined by pulsed field electrophoresis
(PFGE) and refers to strains which are not distinguishable
by treatment with rare cutting DNA restriction enzymes.
However, some strains in pulsotype 2 possessed extended
spectrum beta-lactamase activities, and therefore some
genetic variability existed between these strains. A sum-
mary of the E. sakazakii pulsotypes and neonates is given
in Table 1. Previous publications have not reported the
individual case details associated with the isolates under
study. Therefore, it is not possible to directly consider cor-
relations between in vitro and in vivo studies. This is the
first report studying in vitro virulence assays using clinical
isolates with associated patient details, symptoms and
outcomes.
Results
In vitro virulence determination
The attachment and invasion of Caco-2 human epithelial
cells was determined after a 3-h exposure period with
strains from each E. sakazakii pulsotype and the E. cloacae
strain 766 from the outbreak. S. Enteritidis, a well docu-
mented enteric pathogen capable of attaching and invad-
ing Caco-2 cells was used as a positive control. Pulsotype
1 (strain 696) attached (2.6 ± 0.24% of inoculum) more
than other pulsotypes and S. Enteritidis, (1.4 ± 0.24%),
which was the positive control (Fig. 1). Pulsotype 2 strains
(695, 701, 709 and 767) associated less with epithelial
cells (0.96–0.14% of inoculum) than S.  Enteritidis.
Strains from pulsotypes 3 (693) and 4 (716) also
attached, at relatively low values (0.19 and 0.50%, respec-
tively) compared with S. Enteritidis but greater than the E.
coli K12 negative control (0.04 ± 0.02%). E. cloacae strain
766 attached to Caco-2 cells more abundantly (3.7% of
inoculum) than S. Enteritidis and the E. sakazakii strains.
All strains showed significantly more attachment than E.
coli K12 (p ? 0.001) and significantly more or less than S.
Enteritidis (p ? 0.013).
All strains invaded Caco-2 cells at a significantly (p ?
0.001) greater value than E. coli K12 (0.01% of inocu-
lum), and less than S.  Enteritidis (0.35% of inocu-
lum)(Fig. 2). Strains 701 and 767 invaded at higher
values, 0.17 and 0.23% of inoculum (p ? 0.02), respec-
tively than the other E. sakazakii strains (0.04–0.12% of
inoculum). While not statistically different, there did
appear to be an apparent difference between strains 767
and 701 with S. Enteritidis.
Table 1: Description of E. sakazakii and E. cloacae strains used in this study
Organism Strain number Neonate Isolation site Symptoms Isolation date (day/mn/yr) PFGE profile
E. sakazakii 696 D Stools NEC IIb 08/06/1994 1
E. sakazakii 701 F Peritoneal fluid NEC IIIb (died) 07/04/1994 2
E. sakazakii 767a H Trachea Meningitis (died) 11/05/1994 2
E. sakazakii 709 C Trachea Septicaemia 12/05/1994 2
E. sakazakii 695a J Trachea NEC II (died) 07/06/1994 2
E. sakazakii 693 Q Stools Asymptomatic 18/06/1994 3
E. sakazakii 716 Infant formula 11/07/1994 4
E. cloacae 766 R Blood culture Sepsis (died) 04/06/1994 NAc
a Strains demonstrated extended spectrum ?-lactamase activities.
b NEC Stage II (definite NEC) is characterised by the systemic signs of temperature instability, apnoea, bradycardia, lethargy with additional 
symptoms of absence of bowel sounds, radiological signs of intestinal dilation, ileus and pneumatosis intestinalis. NEC Stage III (advanced NEC) is 
where the neonate is critically ill with metabolic acidosis, neutropenia, signs of generalised peritonitis, marked tenderness and distension of 
abdomen.
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After 24 h within U937 macrophages, significantly higher
numbers of intracellular E. sakazakii were recovered from
strains 701, a pulsotype 2 (p ? 0.04) from a fatal NEC case
and 716, a pulsotype 4 isolated from powdered infant for-
mula (p ? 0.001), than other E. sakazakii strains (Fig. 3).
All E. sakazakii strains persisted and were recovered from
macrophages at detectable levels at 48 h. In contrast to the
E. sakazakii strains, there was significantly less uptake and
persistence of E. cloacae strain 766 in U937 macrophages.
At 24 h, the number of E. cloacae recovered was signifi-
cantly less (p ? 0.05) than the E. sakazakii strains and was
not detectable after 48 h.
E. sakazakii is associated with rare cases of bacterial men-
ingitis. Therefore, we carried out an in vitro study to inves-
tigate the ability of E. sakazakii to invade capillary
endothelial cells which comprise the blood-brain barrier.
E. sakazakii strains from the 4 pulsotypes were used for
invasion studies of rat brain capillary endothelial cells
(rBCEC4). Invasion was evaluated after inoculation (1.5
h) and gentamicin treatment (0.5 h). The E. coli K12 neg-
ative control did not invade this cell line (detection limit
50 cfu/1 × 105 rBCEC4 cells, data not shown). However,
E. sakazakii strain 767 invaded rBCEC4 cells significantly
more than E. sakazakii strains 693, 696, 701, 709 and E.
cloacae strain 766 (p < 0.043; Fig. 4). Strain 767 was from
the fatal meningitis case (neonate F). E. sakazakii strain
695 invaded rBCEC4 cells significantly more than E. saka-
zakii strains 701, 709 and E. cloacae strain 766 (p < 0.017;
Fig. 4). Thus, on average, strains 767, 695, and 716 were
the most invasive. Furthermore, all strains tested (except
E. coli K12 negative control and E. cloacae strain 766) had
p values (p ? 0.081) not significantly different from inva-
sive meningitic E. coli K1 positive control.
Discussion
The strains in this study were from the largest reported
outbreak of E. sakazakii in a NICU, with the most deaths,
that has been reported to-date [6]. In addition, it is the
first report comparing in vitro virulence assays of clinical
Bacteria attached to the Caco-2 epithelial cell surface was enumerated after 3 h by subtracting the number of bacteria recov- ered following gentamicin protection assay at the same time interval, as described in Fig 2 Figure 1
Bacteria attached to the Caco-2 epithelial cell surface was enumerated after 3 h by subtracting the number of bacteria recov-
ered following gentamicin protection assay at the same time interval, as described in Fig 2. Results are presented as the per-
centage of the inoculum associated. Data are means ± standard errors of two independent experiments performed in 
triplicate. E. coli K12 and S. Enteritidis were used as negative and positive controls, respectively.
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isolates with associated patient details and clinical symp-
toms.
E. sakazakii is associated with NEC, bacteraemia, sepsis
and meningitis. Therefore, attachment to intestinal cells
and translocation to systemic tissue are important in the
pathogenesis of the organism. Variations in symptoms for
each pulsotype could have varied according to dose,
neonate age and antibiotic administration. However, pul-
sotype 2 appeared to be more virulent than pulsotypes 1
and 3 based on the number of NEC, septicaemia, menin-
gitis and fatal cases. In addition, strains 695 and 767 in
pulsotype 2 acquired extended spectrum ?-lactamase
activity [6]. It is accepted that other unidentified factors
could have contributed to the number of neonatal cases
and severity of infection, such as duration of exposure.
The attachment of E. sakazakii strains to Caco-2 cells after
a 3-h exposure period was greater than the negative con-
trol (p ? 0.001) E. coli K12 (Fig. 1). Strain 696 (pulsotype
1) attached to a greater extent than the positive control S.
Enteritidis (2.5 and 1.5% respectively). Strain 693 (pulso-
type 3) was from an asymptomatic case and showed lower
attachment values than the E. sakazakii strains which had
caused NEC, and meningitis. The attachment of strain
716, from powdered infant formula, was significantly (p
= 0.026) higher than 693 and 709 (p = 0.017) and similar
to 695, 701 and 767. E. cloacae strain 766 showed the
greatest attachment value (3.6%). There was no direct cor-
relation between attachment and invasion rates of Caco-2
cells. For example, strains 696 and 766 had the highest
attachment rates, yet 701 and 767 had the highest inva-
sion rates (Fig. 1 &2). All E. sakazakii strains and E. cloacae
showed similar potential for invasion. Strains 701 and
767, associated with fatal cases of NEC and meningitis,
showed the highest invasion rates (0.18 and 0.23%). This
suggests that the ability to invade intestinal cells may be a
strong indication of potential virulence and poor out-
come in the neonatal host.
Most E. sakazakii strains persisted in macrophages for 48
h. Strains 701 (pulsotype 2, fatal NEC case) and 716 (pul-
sotype 4 from powdered infant formula) multiplied sig-
nificantly in the first 24 h. Persistence and replication
within macrophages suggests that E. sakazakii possess vir-
ulence mechanisms to withstand the bactericidal activities
Bacterial invasion of Caco-2 epithelial cells was determined by gentamicin protection assay at 0 (T0) and 3 (T3) h Figure 2
Bacterial invasion of Caco-2 epithelial cells was determined by gentamicin protection assay at 0 (T0) and 3 (T3) h. Results are 
presented as the percentage of the inoculum intracellular (% Invasion). Data are means ± standard errors of two independent 
experiments performed in triplicate. E. coli K12 and S. Enteritidis were used as negative and positive controls, respectively.
0.00
0.10
0.20
0.30
0.40
0.50
696
701
767
709
695
693
716
E. cloacae 766
E. coli K12 
S. Enteritids
Strain
%
 
I
n
v
a
s
i
o
n
E. sakazakii BMC Microbiology 2008, 8:64 http://www.biomedcentral.com/1471-2180/8/64
Page 5 of 9
(page number not for citation purposes)
within macrophages and evade the host immune
response. Controls for macrophage persistence (E. coli
K1), killing (E. coli K12), and replication (C. koseri
SMT319) comparatively showed that E. sakazakii strains
could persist within macrophages for at least 48 h and
some strains demonstrated moderate (767 and 696) to
high (701 and 716) levels of replication. In contrast to the
E. sakazakii strains, there was either no uptake of E. cloacae
(strain 766) by U937 macrophage cells, or it was rapidly
killed following macrophage uptake.
E. sakazakii is associated with rare cases of bacterial men-
ingitis. Therefore, the ability to invade cells comprising
the blood-brain barrier was investigated using rat brain
capillary endothelial cell line rBCEC4. E. coli K1 and C.
freundii have been tested in both Human Brain Microvas-
cular Endothelial Cells (HBMEC) and rBCEC4 cells and
show similar levels of invasion, supporting the use of
rBCEC4 cells as a model of BBB cell invasion [15]. The E.
sakazakii strains and E. cloacae 766 were able to invade rat
brain cells at similar levels as E. coli K1 (Fig. 4). E. coli K1
is known to cause acute bacterial meningitis in neonates
and further demonstrates the virulence potential of E.
sakazakii for this host site. E. sakazakii is invasive for capil-
lary endothelial cells and may gain access to the brain via
crossing the normally impenetrable blood-brain barrier
with specific virulence mechanisms [15].
The four pulsotypes have been previously described with
respect to source, patient symptoms, and phenotypic traits
[6]. Pulsotype 4 strains were isolated from an unopened
tin of powdered infant formula and were not associated
with any neonatal infections. It is notable that pulsotype
4 strains showed no protease activity on skimmed milk
agar plates or capsule production. Whether these pheno-
types are related to virulence determinants is unknown,
but are under current investigation.
Human U937 macrophages were used in a gentamicin protection assay with mid-log phase bacteria Figure 3
Human U937 macrophages were used in a gentamicin protection assay with mid-log phase bacteria. Intracellular bacteria were 
enumerated after 24 h (T24) and 48 h (T48). Results are presented as percent intracellular of the inoculum. Data are means ± 
standard errors of two independent experiments performed in triplicate. E. coli K1 (persists), E. coli K12 (killed), and C. koseri 
strain 319 (replicates) were used as controls.
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The outcome of infection due to E. sakazakii will be
dependent upon a number of factors such as birth weight,
age, immune status and antibiotic therapy [7]. In our
study, it was not possible to directly correlate clinical
symptoms and outcomes with in vitro studies. Neverthe-
less, we have shown the invasive potential of E. sakazakii
with intestinal and blood-brain barrier cells. In addition,
E. sakazakii was able to persist and even replicate for a
period within macrophage cells. These traits appear to
facilitate host immune evasion and dissemination. In
addition, E. sakazakii can acquire antibiotic resistance dur-
ing infection, as shown by the acquisition of extended
spectrum ?-lactamase activities by strains 695 and 767.
These two strains were isolated from two neonates, one
month apart (Table 1). There was variation within pulso-
type 2 for attachment and invasion of intestinal and
blood-brain barrier cells. Whether this reflected the varia-
tion in patient symptoms is uncertain. But it is notable
that strain 767 had the highest level of endothelial cell
invasion, greater than E. coli K1, and was isolated from a
fatal meningitis case, the outcome of which could have
been influenced detrimentally by the extended ?-lacta-
mase spectrum activity the strain had acquired due to its
resistance to standard antibiotic therapy.
Strain 766 was initially identified as E. sakazakii and was
isolated from a fatal case of septic shock during the period
of the NICU E. sakazakii outbreak (Table 1). However,
recent 16S rRNA gene sequencing revealed it was E. cloacae
[6]. This strain showed attachment, and invasion of Caco-
2 endothelial cells, no invasion or no survival in macro-
phages, and low invasion of rat brain capillary endothelial
cells. Therefore, it had the ability to attach and invade
intestinal cells, but no propensity for macrophage survival
Gentamicin protection assay with rat rBCEC4 cells Figure 4
Gentamicin protection assay with rat rBCEC4 cells. Bacteria were grown overnight, inoculated and incubated for 1.5 h with 
rBCEC4 cells then treated with gentamicin for 30 min. E. coli K12 (non-invasive) and E. coli K1 (invasive) were used as controls. 
No bacteria were recovered at T0 following gentamicin treatment or following inoculation with E. coli K12. Results for T2 are 
presented as percent intracellular of the initial inoculation after 2 h. Strains without significant difference from E. coli K1 (p ? 
0.18), 716(p ? 0.06) and 695(p ? 0.10), are designated by letter (a-c), respectively. All experimental strains had p values not sig-
nificantly different from invasive (marked 'a'). Data are means ± standard errors from two independent assays performed in 
triplicate.
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or dissemination, nor an ability to invade the brain. It had
however been able to enter to bloodstream and cause fatal
septic shock.
The potential attachment and invasion of host tissue, dis-
semination and invasion of the blood-brain barrier have
been investigated and demonstrated the potential of E. 11
sakazakii to infect exposed neonates. The source of the
three pulsotypes could not definitely be attributed to con-
taminated reconstituted infant formula. Nevertheless the
feeding practices of preparation for 24-h periods, and pro-
longed (>3 h) administration could have enabled bacte-
rial growth in the reconstituted formula and increased the
risk of infection.
Conclusion
While variables such as host factors and treatment strate-
gies determine the outcome of infection, our in vitro stud-
ies evaluated the virulence of the isolates associated with
this outbreak. It was not possible to directly correlate clin-
ical symptoms and outcomes with in vitro studies. Never-
theless, we have shown the variation in invasive potential
of E. sakazakii with intestinal and blood-brain barrier cells
between and within pulsotypes from a neonatal intensive
care unit outbreak. E. sakazakii strains were able to persist
and even replicate for a period within macrophage cells.
These traits appear to facilitate host immune evasion and
dissemination.
Methods
Bacterial strains
All E. sakazakii and E. cloacae strains were from the previ-
ously described outbreak in 1994. The source neonates are
not identifiable and ethical committeee approval was not
required for their reporting here [6] (Table 1). Non-path-
ogenic Escherichia coli K12 HB101, E. coli K1 neonatal
meningitic CSF isolate RS218 (O18 : K1 : H7), Citrobacter
koseri SMT319 (isolated from the cerebrospinal fluid of an
infant with C. koseri meningitis and a brain abscess
obtained from Joseph St Geme III, Washington University
School of Medicine, USA), and Salmonella enterica serovar
Enteritidis (NCTC 3046) from Nottingham Trent Univer-
sity culture collection, were included as control organisms
for the in vitro virulence assays, as appropriate.
Caco-2 attachment and invasion assays
The attachment and invasion assays were performed with
strains of E. sakazakii and E. cloacae as given in Table 1. E.
coli K12 and S. Enteritidis were negative and positive con-
trols, respectively. The assays were primarily based on the
method of Szymanski et al. [16].
Attachment assay
Mammalian cells were seeded at 2 × 104 per well over-
night. The test organism was grown overnight on TSA at
37°C and harvested in tissue culture growth medium. The
organism was then added at 2 × 106 cfu per well and incu-
bated with 5% CO2 at 37°C for 3 h before washing (x3 in
PBS), dislodging (trypsin-EDTA treatment) followed by
lysis with Triton X-100. Bacterial counts were carried out
on TSA at 37°C. Mammalian cell integrity following infec-
tion was qualitatively assessed using trypan blue staining
after a 3-h incubation period. The control for bacterial
attachment/invasion was obtained by immediately (<3
min) aspirating the bacteria off the mammalian cells after
addition, prior to dislodging, lysis and plating on TSA.
This assay enumerated the total number of bacteria asso-
ciated with the mammalian cells after a 3 h incubation
period. These may be attached to the surface or intracellu-
lar. Therefore, the number of attached bacteria was deter-
mined by subtracting the number of intracellular bacteria
following invasion using the gentamicin treatment
described below. Data are presented as the average
number of bacterial colony forming units/well, given that
each well contained 2 × 104 mammalian cells. Values were
compared using the t-test (p = 0.05).
Invasion assays
As per bacterial attachment studies, mammalian cells
were seeded at 2 × 104 per well and incubated overnight
with 5% CO2 at 37°C. The test bacterial strain was grown
overnight on TSA at 37°C and harvested in tissue culture
growth medium. The bacterium was then added at 2 × 106
cfu per well and incubated with 5% CO2 at 37°C for 3 h.
Afterwards, gentamicin was added (25 µg/ml) to each well
and the cells were further incubated for 1 h before wash-
ing, dislodging, lysis and plating on TSA for viable count-
ing. Mammalian cell integrity following infection was
qualitatively assessed using trypan blue staining after the
3-h incubation period. Control counts were obtained by
adding gentamicin (25 µg/ml) to each well and incubat-
ing for 1 h (reported as T0) prior to washing the mamma-
lian cells, dislodging, lysis and plating on TSA.
Each strain was assayed in at least 2 independent assays.
Each assay was performed in triplicate, and the bacterial
viability was determined in duplicate. Selected strains
have been assayed over a 6-month period to determine
the experimental and biological variability of the assays.
The level of detection was 100 cfu/well. Values were statis-
tically assessed using the t-test (p = 0.05).
U937 macrophage uptake studies
The macrophage uptake studies were performed with
strains of E. sakazakii, E. coli K12 (negative control), E. coli
K1 (positive control) and C. koseri (positive control). The
method was based on that by [17] and as utilized in sim-
ilar studies [15,18]. U937 macrophages were obtained
from ATCC (CRL-1593.2) and seeded into 75 ml tissue
culture flasks [19]. Cells were cultivated in RPMI 1640BMC Microbiology 2008, 8:64 http://www.biomedcentral.com/1471-2180/8/64
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medium with 2 mM L-glutamine, and modified to con-
tain 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/L glu-
cose, 1.5 g/L sodium bicarbonate, and supplemented with
10% foetal bovine serum. At least 24 h prior to infection,
cells were treated with 0.1 µg/ml of phorbol 12-myristate
13-acetate (PMA; Sigma), placed in tissue culture plates
and left at 37°C, under 5% CO2 to adhere and become
activated. Cells were gently washed with RPMI to remove
residual PMA, and fresh media was added prior to infec-
tion. U937 human macrophages were seeded at 106 cells
per well. The bacteria were inoculated at 105 cfu per well
for 45 min at 37°C in 5% CO2. After the incubation
period, macrophages were re-suspended in U937 medium
supplemented with 100 µg/ml of gentamicin and incu-
bated for an additional 45 min at 37°C in 5% CO2. Mac-
rophages were then washed twice, lysed with 0.5% Triton
X100, serially-diluted and plated to determine the
number of intracellular bacteria. Trypan blue exclusion
staining indicated that macrophage viability was main-
tained. Results are presented as invasion efficiency
expressed as the percent (%) of inoculum that is intracel-
lular. Data are presented as the average number of bacte-
rial colony forming units/well, given that each well
contains 2 × 104 mammalian cells.
Gentamicin protection assay of blood-brain barrier 
invasion model
Invasion assays were performed using rat brain capillary
endothelial cell line 4 (rBCEC4), a kind gift from I. E.
Blasig (Berlin, Germany). Cells were seeded at 1 × 105/
well into collagen coated 24-well plates and left to adhere
for 48 h in media described by Blasig et al. [20]. Each bac-
terial strain was grown in BHI broth overnight, washed
with PBS and inoculated in triplicate at an m.o.i. of 1:100.
Inoculated cells were incubated with 5% CO2 at 37°C for
1.5 h as described by Badger et al. [21]. In order to quan-
tify bacterial invasion, gentamicin was added (100 µg/ml)
to each well and incubated for 30 min. Then the cells were
washed twice with PBS, trypsin treated, lysed and dilu-
tions were plated on NA. Cell integrity following invasion
was qualitatively assessed using trypan blue staining after
a 2-h incubation period. E. coli K12 (non-invasive) and E.
coli K1 (invasive) were used as negative and positive con-
trols. Data is presented as the percent invasion as deter-
mined by [100 × (number of bacteria recovered/number
of bacteria inoculated)]. Values were statistically evalu-
ated using the t-test.
Authors' contributions
ST and EH designed and carried out the experiments, and
analysed the data. SF was the principal investigator and
supervised the project. SF drafted the manuscript. All
authors revised the manuscript, and approved the final
manuscript.
Acknowledgements
We thank Julie Rainard for translating documents and Juncal Caubilla-Bar-
ron for the original characterisation of the E. sakazakii strains. We also 
thank Nottingham Trent University for their financial support.
References
1. Badger JL, Stins MF, Kim KS: Citrobacter freundii invades and rep-
licates in human brain microvascular endothelial cells.  Infect
Immun 1999, 67:4208-15.
2. Beck-Sague C, Azimi P, Fonseca S, Baltimore R, Powell D, Bland L,
Ardino M, McAllister S, Huberman R, Sinkowitz R: Bloodstream
infections in neonatal intensive care unit patients: results of
a multicenter study.  Pediatr Infect Dis 1994, 13:1110-1116.
3. Blasig IE, Giese H, Schroeter ML, Sporbert A, Utepbergenov DI,
Buchwalow IB, Neubert K, Schonfelder G, Freyer D, Schimke I, Siems
WE, Paul M, Haseloff RF, Blasig R: *NO and oxyradical metabo-
lism in new cell lines of rat brain capillary endothelial cells
forming the blood-brain barrier.  Microvasc Res 2001, 62:114-27.
4. Bowen AB, Braden CR: Invasive Enterobacter sakazakii disease
in infants.  Emerg Infect Dis 2006, 12:1185-1186.
5. Caubilla-Barron J, Forsythe S: Dry stress and survival time of
Enterobacter sakazakii and other Enterobacteriaceae.  Journal of
Food Protection 2007, 70:2111-7.
6. Caubilla-Barron J, Hurrell E, Townsend S, Loc-Carrillo C, Cheetham
P, Fayet O, Prère M-F, Forsythe SJ: Genotypic and phenotyping
analysis of E. sakazakii strains from a fatal outbreak in a neo-
natal intensive care unit in France.  J Clin Microbiol 2007,
45:3979-85.
7. Coignard B, Vaillant V, Vincent J-P, Leflèche A, Mariani P-Kurkdjian,
Bernet C, L'Hériteau F, Sénéchal H, Grimont P, Bingen E, Desenclos
J-C: Infections sévères à Enterobacter sakazakii chez des nou-
veau-nés ayant consommé une préparation en poudre pour
nourrissons, France, octobre-décembre 2004.  Bulletin Epidémi-
ologique Hebdomadaire (INVS) No. 2–3 2006:10-13.
8. Food and Agriculture Organization-World Health Organization
(FAO-WHO): Joint FAO/WHO workshop on Enterbacter saka-
zakii and other microorganisms in powdered infant formula,
Geneva, 2–5 February, 2004.   [http://www.who.int/foodsafety/
micro/jemra/meetings/feb2004/en/]. Date last accessed : 14.6.08
9. Food and Agriculture Organization-World Health Organization
(FAO-WHO): Enterobacter sakazakii and Salmonella in pow-
dered infant Formula. Second Risk Assessment Workshop.
[http://www.who.int/foodsafety/publications/micro/mra6/en/]. WHO
Rome, Italy 16–20th January. Date last accessed : 14.6.08
10. Forsythe SJ: Enterobacter sakazakii and other bacteria in pow-
dered infant milk formula.  Maternal Child Nutr 2005, 1:44-50.
11. Himelright I, Harris E, Lorch V, Anderson M: Enterobacter sakazakii
infections associated with the use of powdered infant for-
mula – Tennessee. 2001.  J Am Med Assoc 2002, 287:2204-2205.
12. Jarvis C: Fatal Enterobacter sakazakii infection associated with
powdered infant formula in a neonatal intensive care unit in
New Zealand.  Am J Infect Control 2005, 33:e19.
13. Mange JP, Stephan R, Borel N, Wild P, Kim KS, Pospischil A, Lehner
A: Adhesive properties of Enterobacter sakazakii to human
epithelial and brain microvascular endothelial cells.  BMC
Microbiol 2006, 6:58.
14. Pagotto FJ, Nazarowec-White M, Bidawid S, Farber JM: Enterobacter
sakazakii : infectivity and enterotoxin production in vitro and
in vivo.  J Food Protect 2003, 66:370-377.
15. Stoll BJ, Hansen N, Fanaroff AA, Lemons JA: Enterobacter sakazakii
is a rare cause of neonatal septicemia or meningitis in VLBW
infants.  J Pediatr 2004, 144:821-3.
16. Sundstrom C, Nilsson K: Establishment and characterization of
a human histiocytic lymphoma cell line (U-937).  Int J Cancer
1976, 17:565-77.
17. Syzmanski C, King M, Haardt M, Armstrong GD: Campylobacter
jejuni motility and invasion of CaCo-2 cells.  Infect Immun 1995,
63:4295-4300.
18. Townsend S, Caubilla Barron J, Loc-Carrillo C, Forsythe S: The pres-
ence of endotoxin in powdered infant formula milk and the
influence of endotoxin and Enterobacter sakazakii on bacte-
rial translocation in the infant rat.  Food Microbiol 2006, 24:67-74.
19. Townsend SM, Gonzalez-Gomez I, Badger JL: fliP influences Citro-
bacter koseri macrophage uptake, cytokine expression andPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Microbiology 2008, 8:64 http://www.biomedcentral.com/1471-2180/8/64
Page 9 of 9
(page number not for citation purposes)
brain abscess formation in the neonatal rat.  J Med Microbiol
2006, 55:1631-40.
20. Townsend SM, Hurrell E, Gonzalez-Gomez I, Lowe J, Frye JG, For-
sythe S, Badger JL: Enterobacter sakazakii invades brain capillary
endothelial cells, persists in human macrophages influencing
cytokine secretion and induces severe brain pathology in the
neonatal rat.  Microbiology 2007, 153:3538-3547.
21. Van Acker J, De Smet F, Muyldermans G, Bougatef A, Naessens A,
Lauwers S: Outbreak of necrotizing enterocolitis associated
with Enterobacter sakazakii in powdered milk formula.  J Clin
Microbiol 2001, 39:293-297.